Abstract
The initiation of immunoglobulin-E (IgE)-mediated allergic responses requires the binding of IgE antibody to its high-affinity receptor, FcεRI. Crosslinking of FcεRI initiates an intracellular signal transduction cascade that triggers the release of mediators of the allergic response. The interaction of the crystallizable fragment (Fc) of IgE (IgE-Fc) with FcεRI is a key recognition event of this process and involves the extracellular domains of the FcεRI α-chain. To understand the structural basis for this interaction, we have solved the crystal structure of the human IgE-Fc–FcεRIα complex to 3.5-Å resolution. The crystal structure reveals that one receptor binds one dimeric IgE-Fc molecule asymmetrically through interactions at two sites, each involving one Cε3 domain of the IgE-Fc. The interaction of one receptor with the IgE-Fc blocks the binding of a second receptor, and features of this interaction are conserved in other members of the Fc receptor family. The structure suggests new approaches to inhibiting the binding of IgE to FcεRI for the treatment of allergy and asthma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Metzger, H. The receptor with high affinity for IgE. Immunol. Rev. 125, 37–48 (1992).
Kinet, J. P. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17, 931– 972 (1999).
Basu, M. et al. Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptor. J. Biol. Chem. 268, 13118–13127 ( 1993).
Keown, M. B. et al. Hydrodynamic studies of a complex between the Fc fragment of human IgE and a soluble fragment of the FcεRI α-chain. Proc. Natl Acad. Sci. USA 92, 1841– 1845 (1995).
Keown, M. B., Ghirlando, R., Mackay, G. A., Sutton, B. J. & Gould, H. J. Basis of the 1:1 stoichiometry of the high affinity receptor FcεRI-IgE complex. Eur. Biophys. J. 25, 471–476 ( 1997).
Daeron, M. Fc receptor biology. Annu. Rev. Immunol. 15, 203–234 (1997).
Turner, H. & Kinet, J. P. Signalling through the high-affinity IgE receptor FcεRI. Nature 402 (Suppl. B), 24–30 (1999).
Ravetch, J. V. & Clynes, R. A. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16, 421–432 (1998).
Cookson, W. The alliance of genes and environment in asthma and allergy. Nature 402 (suppl. B), 5–11 ( 1999).
Jardieu, P. M. & Fick, R. B. Jr IgE inhibition as a therapy for allergic disease. Int. Arch. Allergy Immunol. 118, 112–115 ( 1999).
Chang, T. W. The pharmacological basis of anti-IgE therapy. Nature Biotechnol. 18, 157–162 ( 2000).
Garman, S. C., Kinet, J. P. & Jardetzky, T. S. Crystal structure of the human high-affinity IgE receptor. Cell 95, 951– 961 (1998).
Nissim, A., Jouvin, M. H. & Eshhar, Z. Mapping of the high affinity Fcε-receptor binding site to the third constant region domain of IgE. EMBO J. 10, 101–107 (1991).
Keegan, A. D., Fratazzi, C., Shopes, B., Baird, B. & Conrad, D. H. Characterization of new rat anti-mouse IgE monoclonals and their use along with chimeric IgE to further define the site that interacts with FcεRII and FcεRI. Mol. Immunol. 28, 1149–1154 (1991).
Presta, L. et al. The binding site on human immunoglobulin E for its high affinity receptor. J. Biol. Chem. 269, 26368– 26373 (1994).
Henry, A. J. et al. Participation of the N-terminal region of Cε3 in the binding of human IgE to its high-affinity receptor FcεRI. Biochemistry 36, 15568–15578 (1997).
Granato, D. A. & Neeser, J. R. Effect of trimming inhibitors on the secretion and biological activity of a murine IgE monoclonal antibody. Mol. Immunol. 24, 849– 855 (1987).
Letourneur, O., Sechi, S., Willette-Brown, J., Robertson, M. W. & Kinet, J. P. Glycosylation of human truncated FcεRI α-chain is necessary for efficient folding in the endoplasmic reticulum. J. Biol. Chem. 270, 8249– 8256 (1995).
Kanellopoulos, J. M., Liu, T. Y., Poy, G. & Metzger, H. Composition and subunit structure of the cell receptor for immunoglobulin E. J. Biol. Chem. 255, 9060–9066 (1980).
Robertson, M. W. Phage and Escherichia coli expression of the human high affinity immunoglobulin E receptor α-subunit ectodomain. Domain localization of the IgE-binding site. J. Biol. Chem. 268, 12736– 12743 (1993).
Maxwell, K. F. et al. Crystal structure of the human leukocyte Fc receptor, FcγRIIa. Nature Struct. Biol. 6, 437– 442 (1999).
Sondermann, P., Huber, R. & Jacob, U. Crystal structure of the soluble form of the human FcγRIIb: a new member of the immunoglobulin superfamily at 1.7 Å resolution. EMBO J. 18, 1095–1103 (1999).
Sondermann, P., Jacob, U., Kutscher, C. & Frey, J. Characterization and crystallization of soluble human FcγRII (CD32) isoforms produced in insect cells. Biochemistry 38, 8469– 8477 (1999).
Sanchez, L. M., Penny, D. M. & Bjorkman, P. J. Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand. Biochemistry 38, 9471–9476 (1999).
Shi, J. et al. Interaction of the low-affinity receptor CD23/FcεRII lectin domain with the Fcε3-4 fragment of human immunoglobulin E. Biochemistry 36, 2112–2122 (1997).
Deisenhofer, J., Colman, P. M., Epp, O. & Huber, R. Crystallographic structural studies of a human Fc fragment. II. A complete model based on a Fourier map at 3.5 Å resolution. Hoppe Seylers Z. Physiol. Chem. 357, 1421–1434 ( 1976).
Harris, L. J., Larson, S. B. & McPherson, A. Comparison of intact antibody structures and the implications for effector function. Adv. Immunol. 72, 191–208 (1999).
Schreiber, S. L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287, 1964–1969 (2000).
Mallamaci, M. A. et al. Identification of sites on the human FcεRI α-subunit which are involved in binding human and rat IgE. J. Biol. Chem. 268, 22076–22083 ( 1993).
Hulett, M. D., Witort, E., Brinkworth, R. I., McKenzie, I. F. & Hogarth, P. M. Identification of the IgG binding site of the human low affinity receptor for IgG FcγRII. Enhancement and ablation of binding by site-directed mutagenesis. J. Biol. Chem. 269, 15287–15293 ( 1994).
Hulett, M. D., Witort, E., Brinkworth, R. I., McKenzie, I. F. & Hogarth, P. M. Multiple regions of human FcγRII (CD32) contribute to the binding of IgG. J. Biol. Chem. 270, 21188–21194 (1995).
Cook, J. P. et al. Identification of contact residues in the IgE binding site of human FcεRIα. Biochemistry 36, 15579–15588 (1997).
Hulett, M. D., Brinkworth, R. I., McKenzie, I. F. & Hogarth, P. M. Fine structure analysis of interaction of FcεRI with IgE. J. Biol. Chem. 274, 13345–13352 (1999).
Sayers, I. et al. Amino acid residues that influence FcεRI-mediated effector functions of human immunoglobulin E. Biochemistry 37 , 16152–16164 (1998).
Anderson, C. L., Ryan, D. H., Looney, R. J. & Leary, P. C. Structural polymorphism of the human monocyte 40 kilodalton Fc receptor for IgG. J. Immunol. 138, 2254– 2256 (1987).
Duncan, A. R., Woof, J. M., Partridge, L. J., Burton, D. R. & Winter, G. Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature 332, 563–564 (1988).
Chappel, M. S. et al. Identification of the Fcγ-receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. Proc. Natl Acad. Sci. USA 88, 9036–9040 (1991).
Hulett, M. D., McKenzie, I. F. & Hogarth, P. M. Chimeric Fc receptors identify immunoglobulin-binding regions in human FcγRII and FcεRI. Eur. J. Immunol. 23, 640–645 ( 1993).
Jefferis, R., Lund, J. & Pound, J. D. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol. Rev. 163, 59–76 (1998).
Keown, M. B., Henry, A. J., Ghirlando, R., Sutton, B. J. & Gould, H. J. Thermodynamics of the interaction of human immunoglobulin E with its high-affinity receptor FcεRI. Biochemistry 37, 8863–8869 (1998).
Zheng, Y., Shopes, B., Holowka, D. & Baird, B. Dynamic conformations compared for IgE and IgG1 in solution and bound to receptors. Biochemistry 31, 7446–7456 (1992).
Dorrington, K. J. & Bennich, H. H. Structure–function relationships in human immunoglobulin E. Immunol. Rev. 41, 3–25 (1978).
Otwinowski, Z. & Minor, W. in Methods in Enzymology: Macromolecular Crystallography, Part A (eds Carter, C. W. Jr & Sweet, R. M.) 307–326 (Academic, New York, 1997).
Collaborative Computational Project No. 4. The CCP4 Suite: Programs for Protein Crystallography. Acta Crystallogr. D 50, 760–763 ( 1994).
Kissinger, C. R., Gehlhaar, D. K. & Fogel, D. B. Rapid automated molecular replacement by evolutionary search. Acta Crystallogr. D 55, 484– 491 (1999).
Harris, L. J., Larson, S. B., Hasel, K. W. & McPherson, A. Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 36, 1581–1597 ( 1997).
Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991).
Brunger, A. T. et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905–921 (1998).
Kraulis, P. J. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946 –950 (1991).
Nicholls, A., Sharp, K. A. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Genet. 11, 281–296 (1991).
Acknowledgements
We thank K. Baker, J. Quintana, and D. Keane for help with synchrotron data collection and Y. Wang, G. Sun, and E. Song for technical assistance. Portions of this work were performed at the Dupont-Northwestern-Dow (DND-CAT) Synchrotron Research Center of the Advanced Photon Source and the Advanced Light Source beamline 5.0.2. This research has been supported by the National Institutes of Health (T.S.J.), the Pew Scholars Program in the Biomedical Sciences (T.S.J.), Heska Corporation (T.S.J.), and the American Cancer Society (S.C.G.). Coordinates have been deposited in the PDB with accession number 1F6A.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Garman, S., Wurzburg, B., Tarchevskaya, S. et al. Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα. Nature 406, 259–266 (2000). https://doi.org/10.1038/35018500
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35018500
This article is cited by
-
Neuronal FcεRIα directly mediates ocular itch via IgE-immune complex in a mouse model of allergic conjunctivitis
Journal of Neuroinflammation (2022)
-
The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab
Nature Communications (2020)
-
IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils
Cell Death & Disease (2018)
-
Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody
Scientific Reports (2018)
-
Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction
Nature Communications (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.